News | July 13, 2021
ImCheck Publishes Seminal Paper in Cell Reports Elucidating How Butyrophilins Activate Vγ9Vδ2 T cell Function Against Tumor Cells
Read More
News | June 1, 2021
Alloy Therapeutics and Pyxis Oncology Form Kyma Therapeutics to Develop Novel Immune-Modulating Antibodies for Cancer and Autoimmune Diseases
Read More
News | May 18, 2021
Interius BioTherapeutics Raises $76M Series A Financing to Advance Breakthrough Cell and Gene Therapy Platform
Read More
Press Release | March 31, 2021
Entrada Therapeutics Announces Closing of $116 Million Series B Financing
Read More
